HilleVax Reports Positive Immunogenicity Results For Phase 2b Trial For HIL-214

RTTNews | 1064 days ago
HilleVax Reports Positive Immunogenicity Results For Phase 2b Trial For HIL-214

(RTTNews) - Biopharmaceutical company HilleVax, Inc. (HLVX) reported Monday positive results from a prespecified immunogenicity analysis of the 203 subjects enrolled in the run-in cohort of NEST-IN1 (Norovirus Efficacy and Safety Trial for INfants), the company's ongoing Phase 2b trial for HIL-214, its investigational virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe norovirus-related acute gastroenteritis (AGE) in infants.

These results follow the previously announced positive recommendation from an independent safety data monitoring committee based on this same cohort.

NEST-IN1 is a Phase 2b, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy, safety, and immunogenicity of HIL-214 in infants of approximately 5 months of age at time of initial vaccination at sites in the United States and Latin America.

The study is planned to enroll 3,000 subjects who will be randomized 1:1 to receive a two-dose regimen of either HIL-214 or placebo.

The company said the full NEST-IN1 topline safety and efficacy data remains on-track for the second half of 2023.

For More Such Health News, visit rttnews.com

read more
Singapore Shares May Remain Stuck In Neutral On Tuesday

Singapore Shares May Remain Stuck In Neutral On Tuesday

The Singapore stock market on Monday wrote a finish to the three-day slide in which it had slipped more than 20 points or 0.5 percent. The Straits Times Index now sits just beneath the 4,450-point plateau although it may spin its wheels on Tuesday.
RTTNews | 1h 11min ago
Little Movement Seen For Malaysia Stock Market

Little Movement Seen For Malaysia Stock Market

The Malaysia stock market has finished higher in two of three trading days since the end of the two-day slide in which it had slipped almost 7 point or 0.5 percent. The Kuala Lumpur Composite Index now sits just above the 1,620-point plateau and it's expected to remain in that neighborhood again on Tuesday.
RTTNews | 1h 41min ago
Rally May Stall For Japan Stock Market

Rally May Stall For Japan Stock Market

Ahead of Monday's holiday for Culture Day, the Japan stock market had jumped higher in three straight sessions, advancing almost 2,200 points or 4 percent in that span. The Nikkei 225 now rests just above the 52,400-point plateau although it may run out of steam on Tuesday.
RTTNews | 1h 48min ago
KOSPI Due For Profit Taking On Tuesday

KOSPI Due For Profit Taking On Tuesday

The South Korea stock market has tracked higher in four straight sessions, advancing almost 215 points or 5.3 percent in that span. Now at another fresh record closing high, the KOSPI sits just above the 4,220-point plateau although investors may lock in gains on Tuesday.
RTTNews | 1h 51min ago
Australia Rate Decision On Tap For Tuesday

Australia Rate Decision On Tap For Tuesday

The Reserve Bank of Australia will wrap up its monetary policy meeting and then announce its decision on interest rates, highlighting a light day for Asia-Pacific economic activity. The RBA is widely expected to keep its benchmark lending rate unchanged at 3.60 percent.
RTTNews | 2h 41min ago